Nektar Therapeutics
Records under this name other than the patents Nektar Therapeutics holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 138 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,802,148 | Microparticles and Method for Their Production now held by Ferring B.V. In force · High confidence | In force | High confidence | |
| US 8,349,800 | Von Willebrand Factor- and Factor VIII-Polymer Conjugates Having a Releasable Linkage now held by Takeda Pharmaceutical Company Limited In force · High confidence | In force | High confidence | |
| US 9,493,544 | Von Willebrand Factor- and Factor VIII-Polymer Conjugates Having a Releasable Linkage now held by Takeda Pharmaceutical Company Limited In force · High confidence | In force | High confidence | |
| US 7,967,221 | Prefilming Atomizer now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 8,869,794 | Aerosolization Apparatus with Capsule Puncturing Member now held by BGP Products Operations GmbH In force · High confidence | In force | High confidence | |
| US 7,862,834 | Pharmaceutical Formulation Comprising a Water-Insoluble Active Agent now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 8,133,865 | Von Willebrand Factor-And Factor VIII-Polymer Conjugates Having a Releasable Linkage now held by Takeda Pharmaceutical Company Limited In force · High confidence | In force | High confidence | |
| US 10,207,066 | Aerosolization Apparatus with Capsule Puncture Alignment Guide now held by BGP Products Operations GmbH In force · High confidence | In force | High confidence | |
| US 9,149,539 | Crystalline Naloxol-Peg Conjugate now held by Grünenthal GmbH In force · High confidence | In force | High confidence | |
| US 9,907,855 | N-Optionally Substituted ARYL-2-Oligomer-3-Alkoxypropionamides now held by CGG Services SAS In force · Medium confidence | In force | Medium confidence |